Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

1nhaler

Scottish Inhaler Startup 1nhaler Secures £2.2 Million to Advance Cardboard Drug-Delivery Device Toward Clinical Trials

November 3, 2026 by James O'Brien

Scottish drug‑delivery startup 1nhaler raised £2.2 million, led by Archangels with support from Scottish Enterprise and BBB Investments, to bring its single‑dose cardboard inhaler to clinical testing and prepare for regulatory filing.

Categories Funding Tags €1M–€5M, 1nhaler, Healthtech, Series A, United Kingdom Leave a comment
Browse by Country

Latest

Latvian Proptech Startup Unitoq Secures €155k Pre-seed Funding to Democratize Real Estate InvestmentNov 3, 2026
German AI Startup Conlio Secures €6.4 Million to Automate Freight Forwarding Finance Across EuropeNov 3, 2026
Swedish E-commerce Platform Revolutionrace to Cut 25 Jobs Through AI-Powered Customer Service OverhaulNov 3, 2026
Former Phoenix Court Partner Launches $17M Pre-Seed Fund to Back Europe's AI StartupsNov 3, 2026
Norrsken Evolve Secures 700 Million SEK to Back European Entrepreneurs and High-Potential StartupsNov 3, 2026

EU Markets

European Markets Flash Caution Signals: What This Week's Financial Turbulence Means for Startup FoundersOct 30, 2026
European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026
French Debt Fears, AI Tailwinds, and a New Unicorn: What Europe's Financial Markets Mean for Your Startup This WeekOct 16, 2026
European Markets Flash Warning Signs and Green Lights for Startups This WeekOct 9, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.